Autism-linked gene CHD8 has been shown to exert its strongest effects during a narrowly defined window of fetal brain development, when a population of immature cells in the ventral region of the embryonic brain is being directed toward specific neural and glial fates. In a study published in Nature Communications, researchers at Kanazawa University used genetically engineered mice to reduce Chd8 expression at precisely timed developmental stages. Their results indicate that a midfetal disruption, but not a later fetal disruption, can alter the formation of inhibitory neurons and oligodendrocyte-lineage cells and ultimately produce autism-like behavioral and circuit abnormalities in adulthood.
Autism spectrum disorder is a developmental condition associated with differences in social interaction, communication, sensory processing, and patterns of repetitive or restricted behavior. Although hundreds of genes have been linked to autism, CHD8 is among the most frequently mutated in individuals diagnosed with the condition. The gene encodes chromodomain helicase DNA-binding protein 8, a chromatin remodeler that uses cellular energy to reposition or reorganize nucleosomes. These compact structures, formed when DNA winds around histone proteins, determine how accessible particular genes are to the transcriptional machinery. By changing chromatin accessibility, CHD8 can influence broad developmental programs rather than a single isolated biological pathway.
The precise developmental timing of CHD8 activity has remained difficult to define. CHD8 is expressed in several classes of neural and non-neural cells and has been implicated in the proliferation, differentiation, and maturation of brain cells. This raised a central question: do CHD8 mutations cause abnormalities by disrupting early stem-cell behavior, by interfering with later neuronal maturation, or by affecting several stages at once? To answer it, the Kanazawa team developed mice in which Chd8 expression could be reduced at selected points during embryonic development. This temporal control allowed the researchers to distinguish consequences arising in midfetal life from those caused after the fetal brain had progressed further toward maturation.
The contrast between developmental stages was striking. When Chd8 expression was reduced around embryonic day 14.5, corresponding to a midfetal phase in mice, the animals later displayed abnormal social interaction and anxiety-like behavior. By comparison, reducing Chd8 from embryonic day 17.5 onward did not produce the same behavioral abnormalities. The findings suggest that the biological vulnerability associated with CHD8 is not uniformly distributed across development. Instead, there appears to be a critical interval in which changes in chromatin regulation can redirect the trajectory of brain development in ways that remain detectable long after the original molecular disturbance has ended.
Further experiments pointed to the ventral progenitor cells as a key site of disruption. These immature cells occupy the ventral portion of the developing brain and generate several important populations, including inhibitory neurons and oligodendrocytes. Inhibitory neurons, many of which communicate using the neurotransmitter GABA, suppress excessive activity in neural networks and help maintain the balance between excitation and inhibition. Oligodendrocytes produce myelin, the insulating material that surrounds neuronal axons and accelerates the transmission of electrical signals. Together, these cell types are essential for organizing the timing, stability, and precision of communication throughout the brain.
The researchers found that loss of CHD8 during the midfetal stage excessively promoted the differentiation of ventral progenitor cells. At first glance, increased differentiation might appear beneficial, because differentiation is the process by which immature cells acquire specialized identities. In a developing brain, however, the timing and scale of differentiation are tightly controlled. If progenitor cells leave their developmental pool too quickly or in abnormal proportions, the brain may generate the wrong number or distribution of specific cell types. The study’s results indicate that the midfetal Chd8 mutation disturbed this balance, producing developmental abnormalities among inhibitory neurons and cells destined to become oligodendrocytes.
To determine how these cellular changes affected the mature brain, the team combined gene-expression profiling, histological analysis, spatial transcriptomics, and functional studies performed in living animals. Spatial transcriptomics preserves information about where gene activity occurs within tissue, allowing researchers to link molecular signatures to anatomical locations and cell populations. The analysis revealed regional and cellular changes associated with the altered development of ventral progenitors. In vivo neural-circuit experiments then showed that the changes in inhibitory neurons were accompanied by functional abnormalities in adult neural networks. By selectively stimulating defined neuronal populations and recording the resulting effects, the researchers were able to identify disrupted circuit responses rather than relying only on behavioral observations.
The study also provided evidence that at least some of the abnormalities could be improved. When the researchers genetically restored Chd8 expression during fetal development, both the excessive differentiation of ventral progenitor cells and the abnormal behaviors were ameliorated in the mice. This rescue experiment strengthens the connection between the timing of Chd8 disruption and the later phenotype, while also suggesting that developmental defects may not be entirely irreversible during the fetal period. It does not establish a treatment for autism in humans, nor does it imply that restoring CHD8 after birth would have the same effect. Instead, it identifies a developmental window and a cellular process that may be important targets for future investigation.
The findings offer a more precise model of how a mutation in a chromatin-regulating gene can influence behavior many months after its initial action. Rather than directly encoding a component of a mature social-behavior circuit, CHD8 appears to help control the developmental decisions that create and organize the cells forming that circuit. A transient imbalance in progenitor differentiation during midfetal development may therefore lead to persistent changes in inhibitory signaling, myelination, and network coordination. The authors emphasize that the work was conducted in mice, and autism is biologically and clinically diverse, meaning that the mechanism will require careful validation in human cells, organoids, and additional models. Nevertheless, identifying when and where CHD8 acts provides a framework for studying other autism-associated genes and for exploring therapies designed around specific developmental stages or cell types.
Subject of Research: The role of the autism-associated chromatin-remodeling gene CHD8 in fetal brain development, ventral progenitor-cell differentiation, inhibitory-neuron and oligodendrocyte-lineage development, neural-circuit function, and autistic-like behavior in mice.
Article Title: Defective ventral neurogenesis due to midfetal Chd8 mutation drives autistic-like behavior in mice
News Publication Date: 27 May 2026
Web References: https://doi.org/10.1038/s41467-026-73416-2
References: Nature Communications, “Defective ventral neurogenesis due to midfetal Chd8 mutation drives autistic-like behavior in mice,” DOI: 10.1038/s41467-026-73416-2.
Image Credits: © Nishiyama, M. et al., Kanazawa University (2026)
Keywords: CHD8, Chd8 mutation, autism spectrum disorder, neurodevelopment, ventral progenitor cells, inhibitory neurons, oligodendrocytes, chromatin remodeling, fetal brain development, neural circuits, spatial transcriptomics, mouse model, developmental biology, neuroscience, genetics
